Solgar, Inc. Issues Voluntary Class I Recall of
ABC Dophilus® Powder
888-534-6370, Monday-Friday, 9AM-7PM ET
FOR IMMEDIATE RELEASE – November 14, 2014 – Solgar, Inc., of Leonia, NJ, is voluntarily recalling ABC Dophilus® Powder. The recall was initiated, out of an abundance of caution, because the product was found to contain Rhizopus oryzae, which may cause Mucormycosis. This is a rare infection that may cause health problems to consumers, particularly pre-mature infants/infants, children, and those with weakened immune systems. Although, it may also occur (rarely) in people who are otherwise healthy. Susceptible consumers should consult with their physician or health care provider if they have used this product.
Solgar is notifying consumers and customers not to consume this product.
This product was distributed to: AL, AR, AZ, CA, CT, CO, FL, IA, IL, IN, MI, ME, MO, MA, NC, NE, NY, NJ, NV, OH, OK, PA, PR, UT, TN, TX, VT, KY, WI, WA, UK and Israel through pharmacy, retail stores, wholesale, internet, etc.
Description: Solgar ABC Dophilus® Powder NET Wt. 1.75 oz (50 g)
UPC Code: 0 33984 00010 0
Lot# 074024-01R1, 074024-01, 074024-02 Expiration Date 7/31/15
One complaint has been received to date.
Testing conducted by the Centers for Disease Control revealed the presence of Rhizopus oryzae in 1.75 oz (50 g) containers of Solgar ABC Dophilus Powder.
The distribution of the product has been suspended while FDA and the company continue to investigate the source of the problem.
Risk factors for developing Mucormycosis include: uncontrolled diabetes; cancer; organ transplant; neutropenia (low white blood cells); skin trauma (cuts, scrapes, punctures, or burns). Susceptible consumers should consult with their physician or health care provider.
Consumers who have purchased Solgar ABC Dophilus® Powder are urged not to consume the product and should return it to the place of purchase for a full refund. Consumers with questions may contact the company at 888-534-6370, Monday-Friday, 9AM-7PM ET.